A Phase II trial evaluating feasibility, safety and efficacy of an individually-tailored exercise intervention during chemotherapy for recurrent ovarian cancer (MRFF EPCDR administered by Griffith). (2020-2024)
Experts
Professor
Andreas Obermair
Affiliate of Centre for Extracellular Vesicle Nanomedicine
Centre for Extracellular Vesicle Nanomedicine
Faculty of Health, Medicine and Behavioural Sciences
NHMRC Leadership Fellow
UQ Centre for Clinical Research
Faculty of Health, Medicine and Behavioural Sciences